Tag: drug discovery
Claude ran 64 hours alone and produced 17 scorpion toxin binders
Anthropic's research model screened hundreds of thousands of protein designs to find molecules that latch onto venom neurotoxins.
OpenAI buys Orchestra Bio to manage the lab work AI cannot do
OpenAI has absorbed a drug-development coordination startup and folded it into Rosalind, its life-sciences model family.
Flahy bets clinical decisions belong on a knowledge graph
The healthcare startup links patient data to biological context so a model can see which facts matter.
Microsoft builds a biology world model to cut lab guesswork
Quine pairs a multimodal model of biological systems with a harness that runs experiments computationally first.
Enveda raises $311M to mine nature for new medicines
The biotech hunts drugs in plants and microbes rather than in a synthesis lab, and now has a…
Anthropic’s Claude agents flag a new enzyme family in viral DNA
Roughly 950 Claude agents searching bacterial virus sequences surfaced a previously uncharacterised enzyme system, the first result from…
Anthropic confirms a Bay Area wet lab for model-run biology
The company says its models need real experiments, not only simulated ones, to matter in biology.
Insilico opens its aging biology models and a 328-gene target list
Insilico Medicine has released an open longevity toolkit in Cell, pairing a benchmark with small models that beat…
Danish drugmaker hands Claude Science its research workflows
Novo Nordisk will test Anthropic's Claude Science workbench inside its research operations and use frontier models to speed…
Insilico turns its first profit on AI drug dealmaking
The generative AI biotech posts $35.5M net profit on a first-half revenue surge.
Stanford’s agent swarm designs a cancer drug Merck also found
Stanford's 37,000-agent virtual biotech designed a lung cancer drug that Merck independently developed and validated.